OptiBiotix Health PLC First products in Whole Foods Market Inc (5880G)
09 August 2016 - 7:00AM
UK Regulatory
TIDMOPTI
RNS Number : 5880G
OptiBiotix Health PLC
09 August 2016
OptiBiotix Health plc
("OptiBiotix" or the "Company")
First products in Whole Foods Market Inc
OptiBiotix Health plc (AIM: OPTI), a life sciences business
developing compounds to tackle obesity, high cholesterol,
diabetes and skin care, announces that GoFigure(R) meal
replacement shakes and natural snack bars products are now
available for sale in UK stores of the Whole Foods Market Inc, a
large ($15bn turnover in 2015) American supermarket chain
exclusively featuring healthy foods.
On 26 July 2016, OptiBiotix announced it had completed an
investment to acquire 51% of The Healthy Weight Loss Company which
produces GoFigure(R) products containing SlimBiome(R), OptiBiotix's
patented combination of natural ingredients, identified and
developed by experts to support weight loss. The launch of
SlimBiome(R) in the GoFigure(R) range establishes its use in food
products with customer feedback consistently reporting reduced
hunger, less snacking, and easier weight loss. GoFigure(R) products
will initially be stocked in 8 UK Whole Foods Market Inc shops with
opportunities for further expansion.
Stephen O'Hara, CEO of OptiBiotix, commented: "Following the
success of our online launch we are delighted to have GoFigure
products on the shelves in such a large and well known American
supermarket chain. This is the first retail listing of GoFigure(R)
products in the UK and we hope the precursor for future national
and international listings. The listing expands the range of
commercial opportunities for Slimbiome(R) both as a food or
ingredient and dietary supplement."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
For further information, please contact:
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Contact via Walbrook below
Executive
Cairn Financial Advisers Tel: 020 7148 7900
LLP
Liam Murray
Hybridan LLP (Joint Broker) Tel: 0203 764 2341
Claire Louise Noyce
Peterhouse Corporate Finance Tel: 020 7469 0936
Ltd (Joint Broker)
Lucy Williams / Duncan
Vasey
Walbrook PR Ltd Tel: 020 7933 8780 or
optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which
modify the human microbiome - the collective genome of the microbes
in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial
strains, compounds and formulations, which modulate the human
microbiome and can be used as food ingredients and supplements or
active compounds for the prevention and management of human
metabolic diseases, examples of which include obesity, cholesterol
and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators
that can impact on lipid and cholesterol management, energy harvest
and appetite suppression. The development pipeline is fuelled by
its proprietary OptiScreen(R) and OptiBiotic(R) platform
technologies designed to identify metabolic pathways and compounds
that impact on human physiology and bring potential health
benefits. These platforms are applicable across a wider range of
other human diseases.
Whole Foods Market Inc. is an American supermarket chain
exclusively featuring foods without artificial preservatives,
colors, flavors, sweeteners, and hydrogenated fats.([) As of 2015
it had 91,000 employees, $15.4bn revenue (2015), and 431
supermarkets in the United States, Canada, and the United
Kingdom.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFMGGRKRLGVZM
(END) Dow Jones Newswires
August 09, 2016 02:00 ET (06:00 GMT)